1. MARKETS
  2. SECTOR : PHARMA & BIOTECH
  3. INDUSTRY : MAJOR PHARMACEUTICALS
  4. APELLIS PHARMACEUTICALS INC
Apellis Pharmaceuticals Inc XNAS: APLS

Apellis Pharma Inc Live Stock Price Today, Share Analysis and Chart

Slowing Down Stock
about

Apellis Pharmaceuticals Inc is a commercial-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel therapeutic compounds to treat diseases with high unmet needs through the inhibition of the complement s...

Read More
18.39 -0.99 (-5.11%)
39.67% Fall from 52W High
2.6M
XNAS Volume

XNAS 12 Mar, 2026 5:30 PM (EDT)

Watchlist

Portfolio

Alert
Durability score
Medium Financial Strength
50.0 / 100
Valuation Score
Mid Valuation
38.5 / 100
Momentum Score
Technically Bearish
32.5 / 100
Slowing Down Stock These stocks have medium financials and valuations, but weak momentum indicating decreasing investor interest View Similar Embed DVM
Analyst Price Target
34
1Yr Price target upside is 83%
19 analysts

5

S

13

W

6

O

1

T

SWOT Analysis

Apellis Pharma Inc Live Price Chart

Switch to TradingView


Loading Fundamental data..


Loading data..